首页> 美国卫生研究院文献>Diabetes Care >Erratum. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME LEADER and SUSTAIN-6 Trials. Diabetes Care 2017;40:821–831

【2h】

Erratum. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME LEADER and SUSTAIN-6 Trials. Diabetes Care 2017;40:821–831

机译：勘误表。使用抗糖尿病药物减轻2型糖尿病的心血管风险：EMPA-REG成果领导者和SUSTAIN-6试验的主要心血管结果的回顾。 2017年糖尿病护理； 40：821–831

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Diabetes Care
作者
Sanjay Kaul;
展开▼
作者单位

展开▼
年(卷),期 2018(41),3
年度 2018
页码 640
总页数 1
原文格式 PDF
正文语种
中图分类护理学;
关键词

相似文献

外文文献
专利

1. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials. Diabetes Care 2017;40:821-831 RESPONSE [J] . Kaul Sanjay Diabetes care . 2017,第12期

机译：减轻2型糖尿病患者的心血管风险：empa-reg结果，领导者和维持6次试验的主要心血管成果综述。糖尿病护理2017; 40：821-831回应
2. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials Diabetes Care 2017; 40:821-831 [J] . Feldman-Billard Sylvie Diabetes care . 2017,第12期

机译：减轻2型糖尿病患者的心血管风险抗体药物：综述Empa-Reg结果，领导者和维持-6试验糖尿病护理的主要心血管结果结果2017; 40：821-831.
3. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials (vol 40, pg 821, 2017) [J] . Kaul Sanjay Diabetes care . 2018,第3期

机译：减轻2型糖尿病患者的心血管风险：empa-reg结果，领导者和维持6次试验的主要心血管成果结果（Vol 40，PG 821,2017）审查
4. Local Delivery of Immunomodulatory Drugs to Improve the Outcome of Islets Transplantation in Type 1 Diabetes [C] . Diana Velluto, Teresa De Toni, Vita Manzoli, Society for Biomaterials annual meeting and exposition . 2018

机译：免疫调节药物的局部递送可改善1型糖尿病患者胰岛移植的效果。
5. Health outcomes of patients with type 2 diabetes hospitalized with cardiovascular disease: An assessment of caregivers and glycemic control. [D] . Comellas, Mariceli. 2014

机译：患有心血管疾病的2型糖尿病患者的健康结局：护理人员和血糖控制的评估。
6. Erratum. Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived? Diabetes Care 2017;40:813–820 [O] . Muhammad Abdul-Ghani, Ralph A. DeFronzo, Stefano Del Prato, 2017

机译：勘误表。心血管疾病和2型糖尿病：新时代的来临了吗？ 2017年糖尿病护理； 40：813–820
7. Comment on Kaul. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials. Diabetes Care 2017;40:821–831 [O] . Sylvie Feldman-Billard 2017

机译：评论Kaul。减轻2型糖尿病患者的心血管风险：empa-reg结果，领导者和维持6次试验的主要心血管成果综述。糖尿病护理2017; 40：821-831

Erratum. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME LEADER and SUSTAIN-6 Trials. Diabetes Care 2017;40:821–831

著录项

相似文献

相关主题

期刊订阅